| EC 5.1.3.8 |
| 9001-15-4 | Creatine Phosphokinase |
| EC 3.1.1.1 |
| 9012-33-3 | β-N-AcetylglucosaMinidase |
| EC 3.4.19.3 |
| EC 2.6.1.18 |
| 9036-06-0 | EC 3.4.24.4 |
| 148938-24-3 | EC 3.4.24.18 |
| 9033-16-3 | EC 3.5.4.3 |
| 70132-14-8 | EC 1.4.3.14 |
| 9028-47-1 | EC 1.1.1.40 |
| 9026-22-6 | EC 2.7.7.9 |
| 9048-63-9 | EC 3.3.2.3 |
| 9015-82-1 | EC 3.4.15.1 |
| 9001-65-4 | EC 1.1.1.67 |
| 9000-89-9 | L-Amino Acid Oxidase |
| EC 1.13.11.34 |
| EC 2.6.1.36 |
| 9014-49-7 | EC 3.1.1.3 |
| 9046-28-0 | EC 1.1.3.21 |
| EC 2.4.1.17 |
| EC 1.11.1.13 |
| 9001-45-0 | β-Glucuronidase |
| 9001-64-3 | EC 1.1.1.37 |
| 9016-11-9 | EC 2.7.7.12 |
| EC-90 |
| EC3 |
| 9082-71-7 | EC 1.4.1.9 |
| 9001-60-9 | L-Lactic dehydrogenase |
| 9002-17-9 | Xanthine Oxidase |
| 149371-12-0 | EC 4.2.2.8 |
| 9032-68-2 | EC 3.4.14.1 |
| 9075-63-2 | EC 3.2.1.49 |
| 9055-20-3 | EC 1.11.1.10 |
| 9025-13-2 | Creatininase amidohydrolase |
| EC 4.1.2.5 |
| 9028-36-8 | EC 1.1.1.28 |
| EC 3.4.24.17 |
| EC 2.7.11 |
| EC 1.5.1.3 |
| 9001-86-9 | EC 3.1.4.3 |
| 9028-85-7 | EC 1.2.1.2 |
| 9023-54-5 | EC 5.3.2.1 |
| 9028-12-0 | EC 1.1.1.2 |
| EC 1.6.8.1 |
| 9001-81-4 | EC 5.4.2.2 |
| EC 2.1.1.8 |
| 9000-81-1 | Anticholinesterase |
| 9014-19-1 | EC 6.4.1.1 |
| 9032-89-7 | EC 5.1.3.2 |
| EC 3.2.1.123 |
| EC 1.11.1.1 |
| polynucleotide phosphorylase |
| 9025-32-5 | EC 3.4.13.9 |
| 9001-78-9 | Alkaline Phosphatase |
| EC 1.6.2.4 |
| 9016-17-5 | EC 3.1.6.1 |
| 2392-42-9 | EC 3.4.24.33 |
| (4E)-5-[[(3aS)-3,3aβ,4,5,6,6aβ-Hexahydro-5α-hydroxy-4β-[(1E,3S)-3-hydroxy-1-octenyl]pentalen]-2-yl]-4-pentenoic acid |
| 5-[[(2E,3aS,6aα)-3,3a,4,5,6,6a-Hexahydro-5α-hydroxy-4β-[3-hydroxy-4-methyl-1-octenyl]pentalen]-2(1H)-ylidene]-5-cyanovaleric acid |
| 5-[[(2E,3aS,6aα)-3,3a,4,5,6,6a-Hexahydro-5α-hydroxy-4β-[(E,S)-3-hydroxy-1-octenyl]pentalen]-2(1H)-ylidene]-5-cyanovaleric acid |
| Earlezzhlxys balanced salts (EBSS) with Phenol red |
| Earlezzhlxys balanced salts (EBSS) without Phenol red |
| 3844-31-3 | (2E)-Δ2,2'-Bi[benzo[b]thiophene-3(2H)-one] |
| Earle's Balanced Salt Solution without Sodium Bicarbonate
|
| Earle's Balanced Salt Solution w/o Phenol Red
|
| Earle’s Balanced Salts w/o CaCl2, MgSO4 (Modified) (Powder)
|
| Earle’s Balanced Salts w/o CaCl2, MgSO4, Phenol Red (Powder)
|
| Earle's Balanced Salt Solution 10-Fold Concentrate, w/o Phenol Red, w/o Sodium Bicarbonate
|
| Earle’s Balanced Salts (Powder)
|
| Earle’s Balanced Salts w/o CaCl2, MgSO4 (Powder)
|
| EARLE''S BALANCED SALTS (EBSS) WITH PHENOL RED |
| EARLE''S BALANCED SALTS (EBSS) WITHOUT PHENOL RED |
| EARLE''S BALANCED SALTS (EBSS) |
| EARLE''S BALANCED SALTS (EBSS) WITH 1 G/L D-GLUCOSE |
| EARLE''S BALANCED SALTS (EBSS) WITHOUT CALCIUM AND MAGNESIUM |
| Earle’s Balanced Salts w/o Phenol Red (Powder)
|
| Earle's Balanced Salt Solutionswithout Phenol Red & SodiumBicarbonate
|
| Earle's Balanced Salt Solution 10-Fold Concentrate w/o Sodium Bicarbonate
|
| Earle’s Balanced Salts (10X) (Powder)
|
| Earle’s Balanced Salts w/o MgSO4 (Powder)
|
| EARLGREYTEA |
| EARLI1 protein |
| (7E)-7-[[(3aS,6aS)-Tetrahydro-4-oxo-6β-[(E)-3-[[dimethyl(tert-butyl)silyl]oxy]-1-octenyl]-2,2-dimethyl-4H-cyclopenta-1,3-dioxol]-5-ylidene]heptanoic acid methyl ester |
| 71102-54-0 | EBIDEN |
| early placenta insulin-like peptide |
| 143891-25-2 | early protein O, pseudorabies virus |
| early transcription factor, vaccinia |
| early growth response alpha |
| 147955-31-5 | early cysteine-labeled protein |
| Early Mitotic Inhibitor 1 (Emi1, F-box Only Protein 5, Fbx5)
|
| EARLY GROWTH RESPONSE PROTEIN 1 (HUMAN) |
| EARLY GROWTH RESPONSE PROTEIN 3 (HUMAN) |
| EARLY GROWTH RESPONSE PROTEIN 4 (HUMAN) |
| Early-strength slushing agent for concrete |
| EarlyGrowthResponseProtein1(Egr1) |
| early-expressed protein 1 |
| 147477-75-6 | early gland protein-1 |
| early mitotic inhibitor 1 |
| early light-inducible protein |